Product Information
JUBBONTI 60 MG/ML SYRINGE is a brand biologic product labeled by Sandoz Inc., priced at $1536.9051 per ML under NDC 61314024063. Its NADAC has been published 46 times since Nov 19, 2025.
Strength
60 mg/mL
Manufacturer
Sandoz Inc.NDC
61314024063
Classification
Brand Biologic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
DENOSUMABApproval Type
Biologic (BLA)
FDA Application
BLA761362On Market Since
6/2/2025
Pharmacological Classes
Price Statistics
The NADAC for JUBBONTI 60 MG/ML SYRINGE has been published 46 times since Nov 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1536.9051 per ML |
|---|---|
| All-time high | $1537.8556 (Jul 15, 2026) |
| All-time low | $1520.1200 (Nov 19, 2025) |
| 52-week high | $1537.8556 |
| 52-week low | $1520.1200 |
| Median price | $1536.3181 |
| Average price | $1534.8450 |
| Largest weekly change | +0.9% (Dec 17, 2025) |
| Weeks tracked | 46 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
denosumab market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
RANK Ligand Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JUBBONTI 60 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for JUBBONTI 60 MG/ML SYRINGE, manufactured by Sandoz Inc., is $1536.9051 per ML (NDC 61314024063), effective Sep 30, 2026.
How has the price of JUBBONTI 60 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for JUBBONTI 60 MG/ML SYRINGE has held within roughly two percent of its current level. It has been tracked across 46 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for JUBBONTI 60 MG/ML SYRINGE?
Since Nov 19, 2025, the NADAC for JUBBONTI 60 MG/ML SYRINGE has ranged from a low of $1520.1200 (Nov 19, 2025) to a high of $1537.8556 (Jul 15, 2026), with a median of $1536.3181 per ML.
Are there cheaper alternatives to JUBBONTI 60 MG/ML SYRINGE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as JUBBONTI 60 MG/ML SYRINGE in a comparable dosage form, but none are currently priced below it.
Who manufactures JUBBONTI 60 MG/ML SYRINGE?
JUBBONTI 60 MG/ML SYRINGE (NDC 61314024063) is labeled by Sandoz Inc., and CMS classifies it as a brand biologic product.